C1q Nephropathy in the Pediatric Population: Pathology and Pathogenesis

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 2010 Feb 25

PMID 20180137

Citations 11

Authors

Scott E Wenderfer

Rita D Swinford

Michael C Braun

Affiliations

Soon will be listed here.

Abstract

C1q nephropathy was originally described nearly 25 years ago by Jennette and Hipp. Since that time there have been a limited number of publications on C1q nephropathy, most of them in the pediatric literature. Despite reported incidences as high as 16% in some pediatric biopsy series, a consensus definition on the diagnosis of C1q nephropathy is lacking and its existence as a distinct clinical disease entity remains controversial. The purpose of this review is to discuss the biology of C1q in the context of mechanisms of C1q deposition, and to provide a detailed analysis of the published pediatric case series with a focus on the pathological criteria used to establish the diagnosis of C1q nephropathy as well as long-term outcomes in children.

Citing Articles

Pediatric Bilateral Hypoplastic Kidney Complicated With C1q Nephropathy: A Case Report.

Kanai H, Sawanobori E, Kobayashi A, Goto M Cureus. 2024; 16(7):e63923.

PMID: 39105016 PMC: 11298498. DOI: 10.7759/cureus.63923.

Identification of biomarkers of chronic kidney disease among kidney-derived proteins.

Higashisaka K, Takeya S, Kamada H, Obana M, Maeda M, Kabayama M Clin Proteomics. 2022; 19(1):3.

PMID: 35016606 PMC: 8903635. DOI: 10.1186/s12014-021-09340-y.

Renal Outcome of IgM Nephropathy: A Comparative Prospective Cohort Study.

Chae Y, Yoon H, Chang Y, Kim Y, Kim H, Choi B J Clin Med. 2021; 10(18).

PMID: 34575298 PMC: 8466757. DOI: 10.3390/jcm10184191.

APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis.

Zee J, McNulty M, Hodgin J, Zhdanova O, Hingorani S, Jefferson J Pediatr Nephrol. 2021; 36(9):2747-2757.

PMID: 33646395 PMC: 8524347. DOI: 10.1007/s00467-021-04990-4.

C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics.

Kim K, Son H, Ryu J, Lee H, Han S, Ryu D PLoS One. 2019; 14(4):e0215217.

PMID: 31002691 PMC: 6474651. DOI: 10.1371/journal.pone.0215217.

References

Taggart L, Harris A, El-Dahr S, Iorember F . C1q nephropathy in a child presenting with recurrent gross hematuria. Pediatr Nephrol. 2009; 25(1):165-8. DOI: 10.1007/s00467-009-1290-y. View

Quigg R . Complement and the kidney. J Immunol. 2003; 171(7):3319-24. DOI: 10.4049/jimmunol.171.7.3319. View

Srivastava T, Chadha V, Taboada E, Alon U . C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis. Pediatr Nephrol. 2000; 14(10-11):976-9. DOI: 10.1007/s004670050056. View

Ziccardi R, Tschopp J . The dissociation properties of native C1. Biochem Biophys Res Commun. 1982; 107(2):618-23. DOI: 10.1016/0006-291x(82)91536-4. View

Cortes-Hernandez J, Fossati-Jimack L, Carugati A, Potter P, Walport M, Cook H . Murine glomerular mesangial cell uptake of apoptotic cells is inefficient and involves serum-mediated but complement-independent mechanisms. Clin Exp Immunol. 2002; 130(3):459-66. PMC: 1906558. DOI: 10.1046/j.1365-2249.2002.01998.x. View

Emancipator S . Experimental models of IgA nephropathy. Am J Kidney Dis. 1988; 12(5):415-9. DOI: 10.1016/s0272-6386(88)80037-4. View

Chao T, Rifai A, Ka S, Yang S, Shui H, Lin Y . The endogenous immune response modulates the course of IgA-immune complex mediated nephropathy. Kidney Int. 2006; 70(2):283-97. DOI: 10.1038/sj.ki.5001533. View

van den Dobbelsteen M, van der Woude F, Schroeijers W, van Es L, Daha M . C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells. J Immunol. 1993; 151(8):4315-24. View

Tarshish P, Tobin J, Bernstein J, EDELMANN Jr C . Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol. 1997; 8(5):769-76. DOI: 10.1681/ASN.V85769. View

10.

Rifai A, Millard K . Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA. Clin Exp Immunol. 1985; 60(2):363-8. PMC: 1577018. View

11.

van den Dobbelsteen M, van der Woude F, Schroeijers W, van Es L, Daha M . Both IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells. J Am Soc Nephrol. 1996; 7(4):573-81. DOI: 10.1681/ASN.V74573. View

12.

. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int. 1978; 13(2):159-65. DOI: 10.1038/ki.1978.23. View

13.

Roberti I, Sachdev S, Aronsky A, Kim D . C1q nephropathy in a child with a chromosome 13 deletion. Pediatr Nephrol. 2006; 21(5):737-9. DOI: 10.1007/s00467-006-0046-1. View

14.

Trendelenburg M . Antibodies against C1q in patients with systemic lupus erythematosus. Springer Semin Immunopathol. 2005; 27(3):276-85. DOI: 10.1007/s00281-005-0007-y. View

15.

Davenport A, MacIver A, Mackenzie J . C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome?. Nephrol Dial Transplant. 1992; 7(5):391-6. View

16.

Villiers C, Arlaud G, Painter R, Colomb M . Calcium binding properties of the C1 subcomponents C1q, C1r and C1s. FEBS Lett. 1980; 117(1):289-94. DOI: 10.1016/0014-5793(80)80964-1. View

17.

Hanevold C, Mian A, Dalton R . C1q nephropathy in association with Gitelman syndrome: a case report. Pediatr Nephrol. 2006; 21(12):1904-8. DOI: 10.1007/s00467-006-0261-9. View

18.

Nishida M, Kawakatsu H, Okumura Y, Hamaoka K . C1q nephropathy with asymptomatic urine abnormalities. Pediatr Nephrol. 2005; 20(11):1669-70. DOI: 10.1007/s00467-005-2024-4. View

19.

Iskandar S, Browning M, Lorentz W . C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis. 1991; 18(4):459-65. DOI: 10.1016/s0272-6386(12)80114-4. View

20.

Servais A, Fremeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B . Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet. 2006; 44(3):193-9. PMC: 2598029. DOI: 10.1136/jmg.2006.045328. View